A103 - Cetirizine - CE89G241 - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP...

Preview:

Click to see full reader

Citation preview

Recommended

N CONFIDEilTIAL - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP I... · The quality of overall diagnostic inforsration in the iodixa¡rol27O mg Vnrl group was classified
Documents
Protocol 0858A1 900-09November2011 -Finalart45-paediatric-studies-docs.ema.europa.eu/GROUP L... · 2014-06-11 · EMA Paediatric Web Synopsis Protocol 0858A1-900-09November2011 -Final
Documents
Strattera Summary 8160 - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP A/Atomoxetine... · aged 6 through 16 years who met the Diagnostic and Statistical Manual of Mental
Documents
ANTAZOLINE PHOSPHATE AND NAPHAZOLINE ...art45-paediatric-studies-docs.ema.europa.eu/GROUP A...ANTAZOLINE PHOSPHATE -MILLER & WOLF naphazoline hydrochloride has also been shown to have
Documents
Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP P...Subject Image Created Date 9/12/2011 12:06:38 PM
Documents
Effects and side effects of mydriatic eyedrops In neonatesart45-paediatric-studies-docs.ema.europa.eu/GROUP T/Tropicamide... · Effects and side effects of mydriatic eyedrops In
Documents
Ii - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP F/Foscarnet... · The safety and efficacy of foseamet for prevention of cytomegalovirus (CMV) infection was ... We report
Documents
Efficacy of a pediatric cycloplegic administered as a sprayart45-paediatric-studies-docs.ema.europa.eu/GROUP C/Cyclopentolate... · Efficacy of a pediatric cycloplegic administered
Documents
2. SYNOPSIS - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP L... · 2. SYNOPSIS Name of Sponsor/Company: UCB Pharma SA Belgium Individual Study Table Referring to Module
Documents
Paroxetine 29060 - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP P/Paroxetine/Paroxetine-29060-329...Paroxetine 29060 A Multi-center, Double-blind, Placebo Controlled Study
Documents
art45-paediatric-studies-docs.ema.europa.euart45-paediatric-studies-docs.ema.europa.eu/GROUP I/Iodixanol/DXV… · In conclusion, iodixanol was a safe and efhcacious conEast medium
Documents
coffiL - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP I... · 2014. 6. 11. · coffiL Reference 8 APPROYED Nycomed lnc. Research and Development '\ilayne, Pennsylvania
Documents
Diagnostyka enteropatii wyslekowe] przy TCart45-paediatric-studies-docs.ema.europa.eu/GROUP T...dla odoskrzeiowego zapalenia pluc, ponadlo matego stopniaobrzliki napowiekachgornychorazd
Documents
Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP T... · ment occurred in all patients after 24, 31, and 26 days, seem to be especially susceptible to cardiac toxicity, the
Documents
Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP I... · SUt,MARY OF PROTOCOL AND STUDY PROCEDURES B. c. Inves t i ga tor Dr. J. P. Coulaud ... Median Range Weight (kg) Mean
Documents
The Pediatric Infectious Disease Journal Foscarnet Therapy ...art45-paediatric-studies-docs.ema.europa.eu/GROUP F/Foscarnet... · The Pediatric Infectious Disease Journal • Volume
Documents
18986389.pdf - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP T/treosulfan... · tember 2007 in two Centres (Oncoematologia Pediatrica, Pavia and Centro Trapianti Midollo
Documents
STUDY DRUG - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP T...Thus, the girls' peak response of luteinizing hormone (LH) to a standard gonadotropin-releasing hormone (GnRH)
Documents
III - Europaart45-paediatric-studies-docs.ema.europa.eu/GROUP F...IV weekly for 3-4 weeks and then 400-800mg qds PO for 3 months) in conjunction with IVIG (weekly till D+35 and then
Documents
Boehringer Ingelheim ABCDart45-paediatric-studies-docs.ema.europa.eu/GROUP A... · 2014-06-11 · Name of company: Boehringer Ingelheim Tabulated Trial Report ABCD Synopsis No.: n.a
Documents